Batu Biologics Launches Crowdfunding Campaign

Batu Biologics Launches Crowdfunding Campaign to Complete Preclinical Testing for VallovaxTM Cancer Therapy
San Diego immunotherapy company seeks to raise $100,000 to complete IND enabling experiments for the FDA

We hope to utilize this crowdfunding campaign as a stepping stone toward larger future campaigns. Batu hopes to not only progress the science behind its anti-angiogenic cancer vaccine, VallovaxTM, but to also capitalize on the non-dilutive investment and support from the surrounding community.

Read the full article at businesswire.com

0